Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 261

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Paradoxical gastrointestinal effects of interleukin-17 blockers

Open access
Fauny, Marine, Moulin, David, D'Amico, Ferdinando, Netter, Patrick, Petitpain, Nadine, Arnone, Djesia, Jouzeau, Jean-Yves, Loeuille, Damien, Peyrin-Biroulet, Laurent·2020·Annals of the Rheumatic Diseases

Abstract

Secukinumab, ixekizumab and brodalumab are monoclonal antibody therapies that inhibit interleukin (IL)-17 activity and are widely used for the treatment of psoriasis, psoriatic arthritis and ankylosing spondylitis. The promising efficacy results in dermatology and rheumatology prompted the evaluation of these drugs in Crohn’s disease and ulcerative colitis, but the onset of paradoxical events (disease exacerbation after treatment with a theoretically curative drug) prevented their approval in patients with inflammatory bowel diseases (IBDs). To date, the pathophysiological mechanisms underlying these paradoxical effects are not well defined, and there are no clear guidelines for the management of patients with disease flare or new IBD onset after anti-IL-17 drug therapy. In this review, we summarise the literature on putative mechanisms, the clinical digestive effects after therapy with IL-17 inhibitors and provide guidance for the management of these paradoxical effects in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2020-217927

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 261

Metadata

Authors
Fauny, M., Moulin, D., D'Amico, F., Netter, P., Petitpain, N., Arnone, D., Jouzeau, J.-Y., Loeuille, D., & Peyrin-Biroulet, L.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-09
Volume
79
Issue
9
Pages
1132-1138
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3045091446
Cited by
261
References
76
FWCI
18.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paradoxical gastrointestinal effects of interleukin-17 blockers. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-217927
The paper
Fauny, M., Moulin, D., D'Amico, F., Netter, P., Petitpain, N., Arnone, D., Jouzeau, J.-Y., Loeuille, D., & Peyrin-Biroulet, L. (2020). Paradoxical gastrointestinal effects of interleukin-17 blockers. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.